EverPoint Asset Management’s Edwards Lifesciences EW Stock Holding History

EverPoint Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$15.9M	Buy	507,738 +132,738	+35%	+$4.3M	0.29%	94
2016 Q3	$15.1M	Buy	375,000 +120,000	+47%	+$4.52M	0.27%	97
2016 Q2	$8.48M	Sell	255,000 -60,000	-19%	-$2.05M	0.17%	166
2016 Q1	$9.26M	Buy	315,000 +195,000	+163%	+$5.38M	0.18%	145
2015 Q4	$3.16M	Sell	120,000 -510,000	-81%	-$13.2M	0.07%	332
2015 Q3	$14.9M	Buy	+630,000	New	+$15.2M	0.39%	66
2015 Q2	–	Sell	-210,000	Closed	-$4.99M	–	493
2015 Q1	$4.99M	Sell	210,000 -66,000	-24%	-$1.48M	0.09%	279
2014 Q4	$5.86M	Buy	276,000 +51,000	+23%	+$1.02M	0.13%	228
2014 Q3	$3.83M	Sell	225,000 -675,000	-75%	-$10.7M	0.09%	287
2014 Q2	$12.9M	Buy	+900,000	New	+$12.2M	0.27%	105

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EverPoint Asset Management's EW Position: Q4 2016 in Review

EverPoint Asset Management increased its Edwards Lifesciences (EW) stake by 35% in Q4 2016, buying an estimated $4.3M and bringing the position to 507,738 shares worth $15.9M. The position accounts for 0.29% of the portfolio, ranked #94.

EverPoint Asset Management first reported a position in EW in Q2 2014 and has held it in 10 quarters since. 687 funds tracked by Wall St. Rank hold EW as of Q4 2016.

EverPoint Asset Management held 507,738 shares of Edwards Lifesciences worth $15.9M as of Q4 2016.
EverPoint Asset Management bought 132,738 Edwards Lifesciences shares in Q4 2016, an estimated $4.3M.
Edwards Lifesciences made up 0.29% of EverPoint Asset Management's portfolio in Q4 2016, its #94 holding.
EverPoint Asset Management first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 10 quarters since.
687 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.